ABVX

NASDAQStock

Abivax S.A.

$117.13+4.74 (+4.22%)

52-Week Range

$5.17

$145.31

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-0.38

Volume

2.2M

Avg Volume

909.3K

Performance

-4.72%

-0.79%

+36.23%

YTD

-12.55%

+1876.01%

+1309.40%

Price Chart

ETF Exposure

ABVX is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AADR	DORSEY WRIGHT ADR ETF	2.84%	12,118	$1.6M	$55.5M	1.17%
ATFV	Alger 35 ETF	2.66%	25,786	$287.4M	$108.0M	0.55%
GVIP	Goldman Sachs Hedge Industry VIP ETF	1.91%	73,551	$8.5M	$435.9M	0.45%
FRTY	Alger Mid Cap 40 ETF	1.35%	15,000	$174.3M	$129.1M	0.60%
IBB	iShares Biotechnology ETF	0.53%	385,766	$44.5M	$8.50B	0.44%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.52%	3,337	$385K	$74.5M	0.19%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.35%	2,650	$305K	$86.8M	1.19%
TNXT	T. Rowe Price Innovation Leaders ETF	0.19%	258	$30K	$15.9M	0.49%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.02%	14,090	$1.6M	$9.01B	0.21%
IALT	iShares Systematic Alternatives Active ETF	0.01%	359	$41K	$110.6M	0.99%
TLTD	FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund	0.01%	576	$67K	$619.1M	0.41%
PINK	Simplify Health Care ETF	0.01%	220	$25K	$255.0M	0.51%

About ABVX ETF Exposure

Abivax S.A. (ABVX) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $117.13. Investors can gain exposure to ABVX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABVX, sorted by portfolio weight.